To identify protein candidates for further analysis and validation, we also performed DPE analysis of EGFR mutant NSCLC cell lines individually against HBEC GFP;p53wt, defined as the initial, untransformed stage (Figure 1A). This evidence concerns the gene EGFR and non-small cell lung carcinoma.